302 related articles for article (PubMed ID: 31220547)
1. Alcohol-induced conditioned place preference is modulated by CB2 cannabinoid receptors and modifies levels of endocannabinoids in the mesocorticolimbic system.
Martín-Sánchez A; Warnault V; Montagud-Romero S; Pastor A; Mondragón N; De La Torre R; Valverde O
Pharmacol Biochem Behav; 2019 Aug; 183():22-31. PubMed ID: 31220547
[TBL] [Abstract][Full Text] [Related]
2. Opposing roles of CB
Gobira PH; Oliveira AC; Gomes JS; da Silveira VT; Asth L; Bastos JR; Batista EM; Issy AC; Okine BN; de Oliveira AC; Ribeiro FM; Del Bel EA; Aguiar DC; Finn DP; Moreira FA
Br J Pharmacol; 2019 May; 176(10):1541-1551. PubMed ID: 30101419
[TBL] [Abstract][Full Text] [Related]
3. Genetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2 Receptors in Alcohol Reward-Related Behaviors.
Powers MS; Breit KR; Chester JA
Alcohol Clin Exp Res; 2015 Dec; 39(12):2438-46. PubMed ID: 26756798
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological regulation of cannabinoid CB2 receptor modulates the reinforcing and motivational actions of ethanol.
Navarrete F; García-Gutiérrez MS; Manzanares J
Biochem Pharmacol; 2018 Nov; 157():227-234. PubMed ID: 30063884
[TBL] [Abstract][Full Text] [Related]
5. The anandamide transport inhibitor AM404 reduces ethanol self-administration.
Cippitelli A; Bilbao A; Gorriti MA; Navarro M; Massi M; Piomelli D; Ciccocioppo R; Rodríguez de Fonseca F
Eur J Neurosci; 2007 Jul; 26(2):476-86. PubMed ID: 17650118
[TBL] [Abstract][Full Text] [Related]
6. Cannabis, cannabinoid receptors, and endocannabinoid system: yesterday, today, and tomorrow.
Wu J
Acta Pharmacol Sin; 2019 Mar; 40(3):297-299. PubMed ID: 30670816
[No Abstract] [Full Text] [Related]
7. The roles of cannabinoid CB1 and CB2 receptors in cocaine-induced behavioral sensitization and conditioned place preference in mice.
Lopes JB; Bastos JR; Costa RB; Aguiar DC; Moreira FA
Psychopharmacology (Berl); 2020 Feb; 237(2):385-394. PubMed ID: 31667531
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease.
Köfalvi A; Lemos C; Martín-Moreno AM; Pinheiro BS; García-García L; Pozo MA; Valério-Fernandes Â; Beleza RO; Agostinho P; Rodrigues RJ; Pasquaré SJ; Cunha RA; de Ceballos ML
Neuropharmacology; 2016 Nov; 110(Pt A):519-529. PubMed ID: 26976670
[TBL] [Abstract][Full Text] [Related]
9. 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.
Llorente-Berzal A; Terzian AL; di Marzo V; Micale V; Viveros MP; Wotjak CT
Psychopharmacology (Berl); 2015 Aug; 232(15):2811-25. PubMed ID: 25814137
[TBL] [Abstract][Full Text] [Related]
10. Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects.
Liu QR; Canseco-Alba A; Liang Y; Ishiguro H; Onaivi ES
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371336
[TBL] [Abstract][Full Text] [Related]
11. The cannabinoid receptor 2 agonist, β-caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice.
Al Mansouri S; Ojha S; Al Maamari E; Al Ameri M; Nurulain SM; Bahi A
Pharmacol Biochem Behav; 2014 Sep; 124():260-8. PubMed ID: 24999220
[TBL] [Abstract][Full Text] [Related]
12. Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons.
Canseco-Alba A; Schanz N; Sanabria B; Zhao J; Lin Z; Liu QR; Onaivi ES
Behav Brain Res; 2019 Mar; 360():286-297. PubMed ID: 30508607
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice.
Zhang HY; Gao M; Liu QR; Bi GH; Li X; Yang HJ; Gardner EL; Wu J; Xi ZX
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):E5007-15. PubMed ID: 25368177
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuse.
Vasiljevik T; Franks LN; Ford BM; Douglas JT; Prather PL; Fantegrossi WE; Prisinzano TE
J Med Chem; 2013 Jun; 56(11):4537-50. PubMed ID: 23631463
[TBL] [Abstract][Full Text] [Related]
15. Role of the endocannabinoid system in ethanol-induced inhibition of salivary secretion.
Prestifilippo JP; Fernández-Solari J; Medina V; Rettori V; Elverdin JC
Alcohol Alcohol; 2009; 44(5):443-8. PubMed ID: 19589828
[TBL] [Abstract][Full Text] [Related]
16. Functional CB2 type cannabinoid receptors at CNS synapses.
Morgan NH; Stanford IM; Woodhall GL
Neuropharmacology; 2009 Sep; 57(4):356-68. PubMed ID: 19616018
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats.
Delis F; Polissidis A; Poulia N; Justinova Z; Nomikos GG; Goldberg SR; Antoniou K
Int J Neuropsychopharmacol; 2017 Mar; 20(3):269-278. PubMed ID: 27994006
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
Forget B; Guranda M; Gamaleddin I; Goldberg SR; Le Foll B
Psychopharmacology (Berl); 2016 May; 233(10):1823-8. PubMed ID: 26864774
[TBL] [Abstract][Full Text] [Related]
19. Interactions between ethanol and the endocannabinoid system at GABAergic synapses on basolateral amygdala principal neurons.
Talani G; Lovinger DM
Alcohol; 2015 Dec; 49(8):781-94. PubMed ID: 26603632
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoids drive the acquisition of an alternative phenotype in microglia.
Mecha M; Feliú A; Carrillo-Salinas FJ; Rueda-Zubiaurre A; Ortega-Gutiérrez S; de Sola RG; Guaza C
Brain Behav Immun; 2015 Oct; 49():233-45. PubMed ID: 26086345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
